Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway
Authors:
- Koichiro KamioKKKoichiro Kamio
- Jiro UsukiJUJiro Usuki
- Arata AzumaAAArata Azuma
- Kuniko MatsudaKMKuniko Matsuda
- Takeo IshiiTITakeo Ishii
- Minoru InomataMIMinoru Inomata
- Hiroki HayashiHHHiroki Hayashi
- Nariaki KokuhoNKNariaki Kokuho
- Kazue FujitaKFKazue Fujita
- Yoshinobu SaitoYSYoshinobu Saito
- Toshimichi MiyaTMToshimichi Miya
- Akihiko GemmaAGAkihiko Gemma
- 1 June 2015
- journal article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 32, 29-36
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2014
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2014
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Pirfenidone in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2009
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor EfficacyCancer Research, 2008
- Immunoregulatory functions of surfactant proteinsNature Reviews Immunology, 2005
- Serum surfactant proteins‐A and ‐D as biomarkers in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2002
- Lung surfactant proteins involved in innate immunityCurrent Opinion in Immunology, 1999
- Collectins and Pulmonary Host DefenseAmerican Journal of Respiratory Cell and Molecular Biology, 1998